Cinacalcet recalls: lots, NDC and companies
9 FDA recall records mention Cinacalcet since December 11, 2024. Each covers specific lots from one company. Check yours below.
Check your Cinacalcet bottle
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Dissolution
STRIDES PHARMA INC: Cinacalcet Tablets
Hazard (FDA): Failed dissolution specifications
FDAMedicines
Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more
Hazard (FDA): cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
FDAMedicines
Amgen, Inc.: Corlanor and 4 more
Hazard (FDA): Presence of Foreign Substance. CGMP Deviations
FDAMedicines
Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more
Hazard (FDA): CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
FDAMedicines
Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more
Hazard (FDA): CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
FDAMedicines
Dissolution
Strides Pharma, Inc.: Cinacalcet Tablets 90 mg
Hazard (FDA): Failed Dissolution Specifications.
FDAMedicines
Slate Run Pharmaceuticals: Cinacalcet Hydrochloride Tablets 30 mg and 1 more
Hazard (FDA): CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
FDAMedicines
AvKARE: Cinacalcet Tablets and 2 more
Hazard (FDA): CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
FDAMedicines
Aurobindo Pharma USA Inc: Cinacalcet Tablets and 2 more
Hazard (FDA): cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
FDAMedicines